Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BICYCLE THERAPEUTICS PLCBCYC · Entity 5993 | Director | January 02, 2026 | January 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BICYCLE THERAPEUTICS PLC
Report date January 02, 2026 · Filed January 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 196,427 |
Reported balance
After 2026-01-02 transaction · row 1
1 source rowRow 1 · 2026-01-02 · Grant · Acquired 9,500 · Balance 196,427 F1: Represents a restricted share unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026. F2: Each RSU represents a contingent right to receive one ordinary share. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.08 · Expires 2036-01-02 | Direct | 19,000 |
Reported balance
After 2026-01-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-01-02 · Grant · Acquired 19,000 · Balance 19,000 F3: This option shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted share unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026.
F2: Each RSU represents a contingent right to receive one ordinary share.
F3: This option shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2026 Filed Jan 7, 2026 01:00 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantStock Option (right to buy) · Derivative | 19,000 | $0.00 Strike: $7.08 | $0.00 |
DisclosureSEC source: 0001777021-26-000002 · form4-01062026_080109.xml · derivative · entry 2 Winter Gregory Paul · CIK 0001777021 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,000 Underlying: Ordinary Shares · 19,000 shares Expires 2036-01-02 F3 · derivative.exercise_date: This option shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026. Read SEC document |
| January 02, 2026 Filed Jan 7, 2026 01:00 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantOrdinary Shares | 9,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001777021-26-000002 · form4-01062026_080109.xml · nonDerivative · entry 1 Winter Gregory Paul · CIK 0001777021 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,427 F1 · shares: Represents a restricted share unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026. F2 · price: Each RSU represents a contingent right to receive one ordinary share. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 00:30 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001415889-25-000920 · form4-01062025_070110.xml · derivative · entry 2 Winter Gregory Paul · CIK 0001777021 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Ordinary Shares · 12,500 shares Expires 2035-01-02 F3 · derivative.exercise_date: This option shall vest in four equal installments on March 15, 2025, June 15, 2025, September 15, 2025 and December 15, 2025. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 00:30 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantOrdinary Shares | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-000920 · form4-01062025_070110.xml · nonDerivative · entry 1 Winter Gregory Paul · CIK 0001777021 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,927 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2025, June 15, 2025, September 15, 2025 and December 15, 2025. F2 · price: Each RSU represents a contingent right to receive one ordinary share. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 23:31 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $18.08 | $0.00 |
DisclosureSEC source: 0001209191-24-000882 · doc4.xml · derivative · entry 2 Winter Gregory Paul · CIK 0001777021 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Underlying: Ordinary Shares · 12,000 shares Expires 2034-01-02 F3 · derivative.exercise_date: This option shall vest in four equal installments on March 15, 2024, June 15, 2024, September 15, 2024 and December 15, 2024. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 23:31 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantOrdinary Shares | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-000882 · doc4.xml · nonDerivative · entry 1 Winter Gregory Paul · CIK 0001777021 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,677 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2024, June 15, 2024, September 15, 2024 and December 15, 2024. F2 · price: Each RSU represents a contingent right to receive one ordinary share. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:23 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantStock Option (right to buy) · Derivative | 11,500 | $0.00 Strike: $29.60 | $0.00 |
DisclosureSEC source: 0001209191-23-002216 · doc4.xml · derivative · entry 2 Winter Gregory Paul · CIK 0001777021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,500 Underlying: Ordinary Shares · 11,500 shares Expires 2033-01-03 F3 · derivative.exercise_date: This option shall vest in four equal installments on March 15, 2023, June 15, 2023, September 15, 2023 and December 15, 2023. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:23 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantOrdinary Shares | 5,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002216 · doc4.xml · nonDerivative · entry 1 Winter Gregory Paul · CIK 0001777021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,677 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2023, June 15, 2023, September 15, 2023 and December 15, 2023. F2 · price: Each RSU represents a contingent right to receive one ordinary share. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 22:27 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $60.87 | $0.00 |
DisclosureSEC source: 0001209191-22-001832 · doc4.xml · derivative · entry 2 Winter Gregory Paul · CIK 0001777021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2032-01-03 F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 22:27 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantOrdinary Shares | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-001832 · doc4.xml · nonDerivative · entry 1 Winter Gregory Paul · CIK 0001777021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,927 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs are fully vested. F2 · price: Each RSU represents a contingent right to receive one ordinary share. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:50 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantStock Option (right to buy) · Derivative | 19,000 | $0.00 Strike: $17.95 | $0.00 |
DisclosureSEC source: 0001209191-21-001427 · doc4.xml · derivative · entry 1 Winter Gregory Paul · CIK 0001777021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,000 Underlying: Ordinary Shares · 19,000 shares Expires 2031-01-04 Read SEC document |
| April 14, 2020 Filed Apr 16, 2020 20:09 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionSeries A Preferred Shares Warrant · Derivative | 71,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-024640 · doc4.xml · derivative · entry 2 Winter Gregory Paul · CIK 0001777021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,450 Underlying: Ordinary Shares · 71,450 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Warrants to purchase Series A Preferred Shares had an exercise price of a nominal value per Series A Preferred Share, and, following Bicycle Therapeutics plc's initial public offering, became exercisable for ordinary shares. The Warrants are immediately exercisable and expire on May 26, 2027. F1 · derivative.exercise_date: The Warrants to purchase Series A Preferred Shares had an exercise price of a nominal value per Series A Preferred Share, and, following Bicycle Therapeutics plc's initial public offering, became exercisable for ordinary shares. The Warrants are immediately exercisable and expire on May 26, 2027. F1 · derivative.expiration_date: The Warrants to purchase Series A Preferred Shares had an exercise price of a nominal value per Series A Preferred Share, and, following Bicycle Therapeutics plc's initial public offering, became exercisable for ordinary shares. The Warrants are immediately exercisable and expire on May 26, 2027. Read SEC document |
| April 14, 2020 Filed Apr 16, 2020 20:09 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionOrdinary Shares | 71,450 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-024640 · doc4.xml · nonDerivative · entry 1 Winter Gregory Paul · CIK 0001777021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,927 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Warrants to purchase Series A Preferred Shares had an exercise price of a nominal value per Series A Preferred Share, and, following Bicycle Therapeutics plc's initial public offering, became exercisable for ordinary shares. The Warrants are immediately exercisable and expire on May 26, 2027. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:11 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantStock Option (right to buy) · Derivative | 16,000 | $0.00 Strike: $9.82 | $0.00 |
DisclosureSEC source: 0001209191-20-002003 · doc4.xml · derivative · entry 1 Winter Gregory Paul · CIK 0001777021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Ordinary Shares · 16,000 shares Expires 2030-01-02 Read SEC document |
| May 28, 2019 Filed May 31, 2019 01:27 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | ConversionSeries A Preferred Shares · Derivative | 42,870 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-19-032919 · a4.xml · derivative · entry 2 Winter Gregory Paul · CIK 0001777021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 42,870 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Series A Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date. F1 · price: Each Series A Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date. F1 · derivative.exercise_date: Each Series A Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date. F1 · derivative.expiration_date: Each Series A Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date. Read SEC document |
| May 28, 2019 Filed May 31, 2019 01:27 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | ConversionOrdinary Shares | 42,870 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-19-032919 · a4.xml · nonDerivative · entry 1 Winter Gregory Paul · CIK 0001777021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,477 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Series A Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.